Dustin James Maly

USPTO Granted Patents = 13 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

11 out of 2,099

University of Washington

patents

7 out of 15,458

University of California

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391669 - Substituted pyrimidines as IRE1 kinase inhibitors (2025-08-19),

2. 11884649 - IRE1α inhibitors and uses thereof (2024-01-30),

3. 11840523 - IRE1α inhibitors and uses thereof (2023-12-12),

4. 11649237 - Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition (2023-05-16),

5. 11613544 - Substituted imidazo[1,5-a]pyrazines for modulation of IRE1 (2023-03-28),

6. 11247972 - Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases (2022-02-15),

7. 10822340 - Substituted imidazolopyrazine compounds and methods of using same (2020-11-03),

8. 10632122 - Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases (2020-04-28),

9. 10544104 - Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases (2020-01-28),

10. 10350211 - Bumped kinase inhibitor compositions and methods for treating cancer (2019-07-16),

11. 10307425 - Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases (2019-06-04),

12. 10131668 - Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1 (2018-11-20),

13. 9765037 - Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases (2017-09-19),

Title: Dustin James Maly: Pioneering Innovation in Biomedical Research

Introduction:

Dustin James Maly is a brilliant inventor based in Seattle, WA, known for his groundbreaking work in the field of biomedical research. With 12 patents to his name, Maly is recognized for his relentless pursuit of innovative solutions to complex medical challenges.

Latest Patents:

His latest patents include "IRE1α inhibitors and uses thereof," which highlight compounds designed to inhibit IRE1α, a key protein involved in cellular stress responses. Additionally, Maly's patent on "substituted quinazolin-2-amines and isoquinolin-3-amines" showcases his expertise in developing novel molecules for inhibiting IRE1α.

Career Highlights:

Maly's illustrious career features significant contributions made while working at esteemed institutions such as the University of California and the University of Washington through its Center for Commercialization. His work underscores a deep commitment to advancing the frontiers of biomedical science.

Collaborations:

During his tenure, Maly collaborated with notable researchers including Wesley C Van Voorhis and Kayode K Ojo. These partnerships have been instrumental in driving forward innovative projects and fostering a culture of collaboration within the scientific community.

Conclusion:

In conclusion, Dustin James Maly emerges as a trailblazer in the realm of inventions, particularly within the biomedical research domain. His visionary approach to problem-solving and dedication to scientific excellence continue to inspire aspiring inventors and researchers worldwide. Maly's impact resonates not only through his patents but also through the lasting legacy of innovation he has cultivated throughout his career.

This text is generated by artificial intelligence and may not be accurate.